Market Place
Sourcing Support
Halozyme, Vertex Pharma Partner on Hypercon Technology
07 Apr 2026 //
PR NEWSWIRE
Vertex Taps Halozyme In $15M Upfront Biologics Drug Delivery Deal
07 Apr 2026 //
FIERCE PHARMA
Vertex To Report Q1 2026 Financial Results On May 4
06 Apr 2026 //
PHARMIWEB
Vertex Announces Positive Week 36 Interim Analysis Results
09 Mar 2026 //
BUSSINESSWIRE
Vertex Terminates 20 in Reorganization Push
09 Mar 2026 //
BIOSPACE
Vertex To Participate In Upcoming March Investors Conferences
05 Mar 2026 //
BUSINESSWIRE
Vertex To Present At TD Cowen 46th Annual Health Care Conference
17 Feb 2026 //
BUSINESSWIRE
Vertex Releases 2025 Q4 And Full-Year Financial Results
12 Feb 2026 //
BUSINESSWIRE
Vertex to Announce Q4, Full-Year 2025 Results on Feb. 12
20 Jan 2026 //
BUSINESSWIRE
Vertex Pharma Updates Pipeline, Business Before Investor Day
11 Jan 2026 //
BUSINESSWIRE
Vertex To Present At J.P. Morgan Healthcare Conference
22 Dec 2025 //
BUSINESSWIRE
Vertex To Attend Citi`s 2025 Global Healthcare Conference
19 Nov 2025 //
BUSINESSWIRE
As Vertex`s Pain Launch Gains More Use, Sales Just Missed in Q3
04 Nov 2025 //
FIERCE PHARMA
Vertex Reports Third Quarter 2025 Financial Results
03 Nov 2025 //
BUSINESSWIRE
Vertex To Present At UBS Global Healthcare Conference
27 Oct 2025 //
BUSINESSWIRE
Vertex To Report Q3 2025 Financial Results On November 3
06 Oct 2025 //
PHARMIWEB
Vertex to Attend September Investor Conferences
20 Aug 2025 //
BUSINESSWIRE
Vertex`s Trial Failure, Scrapped Study Cloud Pain Drug Push
05 Aug 2025 //
REUTERS
Vertex Reports Ph2 Results Of VX-993 In Acute Pain
04 Aug 2025 //
BUSINESSWIRE
Vertex Reports Second Quarter 2025 Financial Results
04 Aug 2025 //
BUSINESSWIRE
Vertex Wins Award for JOURNAVX Non-Opioid Pain Therapy
14 Jul 2025 //
BUSINESSWIRE
Vertex, NHS England Agree on Reimbursement for Alyftrek
14 Jul 2025 //
BUSINESSWIRE
Vertex`s Q2 2025 Financial Results Announcement on August 4th
08 Jul 2025 //
BUSINESSWIRE
EU Approves Vertex`s Next-Generation Cystic Fibrosis Drug
02 Jul 2025 //
REUTERS
Vertex Shows Zimislecel Diabetes Data at ADA Session
20 Jun 2025 //
BUSINESSWIRE
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis
06 Jun 2025 //
BUSINESSWIRE
Vertex`s international sales slide with IP `violation` in Russia
06 May 2025 //
FIERCE PHARMA
Vertex Reports First Quarter 2025 Financial Results
05 May 2025 //
BUSINESSWIRE
Vertex Researcher Paul Negulescu Ph.D. Wins 2025 Canada Gairdner
11 Apr 2025 //
BUSINESSWIRE
Vertex to Announce Q1 2025 Financial Results on May 5th
07 Apr 2025 //
BUSINESSWIRE
Vertex Gets UK MHRA Nod For Alyftrek In Cystic Fibrosis
07 Mar 2025 //
BUSINESSWIRE
Vertex to Participate in Upcoming March Investor Conferences
18 Feb 2025 //
BUSINESSWIRE
Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand
11 Feb 2025 //
REUTERS
Vertex challenger Sionna prices $191M IPO
06 Feb 2025 //
BIOPHARMADIVE
CenExel Celebrates FDA Approval of Journax
06 Feb 2025 //
ACCESSWIRE
US FDA approves Vertex`s non-opioid painkiller
31 Jan 2025 //
FDA
Vertex Updates Pipeline & Business Ahead Of Investor Meetings
12 Jan 2025 //
BUSINESSWIRE
Vertex, Zai Lab Partner To Treat Autoimmune Diseases In Asia
10 Jan 2025 //
BIOSPECTRUM
Vertex to Present at 43rd Annual J.P. Morgan Healthcare Conference
23 Dec 2024 //
BUSINESSWIRE
Vertex Announces FDA Approval for Trikafta to Non-F508del Variants
20 Dec 2024 //
BUSINESSWIRE
Vertex Dips on Mixed Ph 2 Data for Non-Opioid Pain Therapy
20 Dec 2024 //
BIOSPACE
Vertex`s pain prospect underwhelms versus placebo, sinking stock
19 Dec 2024 //
FIERCE BIOTECH
Vertex`s Casgevy breaks ground with 1st commercial infusions
05 Nov 2024 //
FIERCE PHARMA
Vertex Reports Third Quarter 2024 Financial Results
04 Nov 2024 //
BUSINESSWIRE
Vertex to Participate in Upcoming November Investor Conferences
29 Oct 2024 //
BUSINESSWIRE
Undaunted Vertex closes in on FDA nod for non-opioid pain drug
28 Oct 2024 //
FIERCE BIOTECH
Vertex Updates on Kidney Programs at ASN Annual Kidney Week
25 Oct 2024 //
BUSINESSWIRE
Rectify drug repairs bile composition in mice with liver disease
22 Oct 2024 //
FIERCE BIOTECH
Vertex pain data: Combo results, Vicodin miss and stellar safety
21 Oct 2024 //
FIERCE BIOTECH
Vertex To Present Phase 3 Data On Suzetrigine At ASA Meeting
18 Oct 2024 //
BUSINESSWIRE
Vertex To Announce Q3 2024 Results On November 4th
10 Oct 2024 //
BUSINESSWIRE
Vertex survey delves into current difficulties in pain treatment
10 Oct 2024 //
FIERCE PHARMA
Vertex Presents CF Data At North American Conference
26 Sep 2024 //
BUSINESSWIRE
Vertex adds CDMO Lonza to Casgevy production network
24 Sep 2024 //
FIERCE PHARMA
Vertex goes all in on September`s bumper awareness month push
04 Sep 2024 //
FIERCE PHARMA
LinkedIn Post Lands Vertex In Hot Water With MHRA Over UK Ad Regulations
22 Aug 2024 //
FIERCE PHARMA
US Q2 earnings growth estimate dips, reflecting Vertex loss, LSEG says
03 Aug 2024 //
REUTERS
Vertex lifts sales guidance as Casgevy launch picks up
03 Aug 2024 //
FIERCE PHARMA
Vertex Reports Second Quarter 2024 Financial Results
01 Aug 2024 //
BUSINESSWIRE
Vertex Raises Forecast On Strong Cystic Fibrosis Treatment Demand
01 Aug 2024 //
REUTERS
